Perphenazine for schizophrenia

Comparative Efficacy and Tolerability of 15 Antipsychotic Drugs in Schizophrenia: A Multiple-Treatments Meta-Analysis

“…The network could be expanded to old drugs such as perphenazine and sulpiride, which have had good results in effectiveness studies, 55,56 but only a few relevant perphenazine trials have been done. 57 As more and more second-generation antipsychotics are losing their patent protection, the debate about the costs of the original second-generation antipsychotics becomes less important. The present debate is about whether …”

Comparative Efficacy and Tolerability of 15 Antipsychotic Drugs in Schizophrenia: A Multiple-Treatments Meta-Analysis

“…The network could be expanded to old drugs such as perphenazine and sulpiride, which have had good results in effectiveness studies, 55,56 but only a few relevant perphenazine trials have been done. 57 As more and more second-generation antipsychotics are losing their patent protection, the debate about the costs of the original second-generation antipsychotics becomes less important. The present debate is about whether …”

60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response

“…We searched the Cochrane-Schizophrenia-Group-Controlled-Trials-Register (compiled by regular systematic searches of more than 15 databases, clinical trial registers, the FDA website, hand searches and conference proceedings (Adams et al, 2011), without language restrictions, available to us until version August 2009) with the term "placebo;" and we searched MEDLINE, EMBASE, PsychInfo, Cochrane CENTRAL and ClinicalTrials.gov (last search October 2016, search terms are presented in the online supplement S3), supplemented by screening previous reviews (Adams et al, 2007;Agid et al, 2013;Fenton et al, 2007;Hartung et al, 2005;Joy et al, 2007;Klein and Davis, 1969;Leucht et al, 2009;Leucht et al, 2013a;Matar and Almerie, 2007;Omori and Wang, 2009;Shen et al, 2012).…”

Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments

“……”

“……”

Comparative Efficacy and Tolerability of 15 Antipsychotic Drugs in Schizophrenia: A Multiple-Treatments Meta-Analysis

“…The network could be expanded to old drugs such as perphenazine and sulpiride, which have had good results in effectiveness studies, 55,56 but only a few relevant perphenazine trials have been done. 57 As more and more second-generation antipsychotics are losing their patent protection, the debate about the costs of the original second-generation antipsychotics becomes less important. The present debate is about whether …”

60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response

“…We searched the Cochrane-Schizophrenia-Group-Controlled-Trials-Register (compiled by regular systematic searches of more than 15 databases, clinical trial registers, the FDA website, hand searches and conference proceedings (Adams et al, 2011), without language restrictions, available to us until version August 2009) with the term "placebo;" and we searched MEDLINE, EMBASE, PsychInfo, Cochrane CENTRAL and ClinicalTrials.gov (last search October 2016, search terms are presented in the online supplement S3), supplemented by screening previous reviews (Adams et al, 2007;Agid et al, 2013;Fenton et al, 2007;Hartung et al, 2005;Joy et al, 2007;Klein and Davis, 1969;Leucht et al, 2009;Leucht et al, 2013a;Matar and Almerie, 2007;Omori and Wang, 2009;Shen et al, 2012).…”

Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments

“……”

“……”

Comparative Efficacy and Tolerability of 15 Antipsychotic Drugs in Schizophrenia: A Multiple-Treatments Meta-Analysis

“…The network could be expanded to old drugs such as perphenazine and sulpiride, which have had good results in effectiveness studies, 55,56 but only a few relevant perphenazine trials have been done. 57 As more and more second-generation antipsychotics are losing their patent protection, the debate about the costs of the original second-generation antipsychotics becomes less important. The present debate is about whether …”

60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response

“…We searched the Cochrane-Schizophrenia-Group-Controlled-Trials-Register (compiled by regular systematic searches of more than 15 databases, clinical trial registers, the FDA website, hand searches and conference proceedings (Adams et al, 2011), without language restrictions, available to us until version August 2009) with the term "placebo;" and we searched MEDLINE, EMBASE, PsychInfo, Cochrane CENTRAL and ClinicalTrials.gov (last search October 2016, search terms are presented in the online supplement S3), supplemented by screening previous reviews (Adams et al, 2007;Agid et al, 2013;Fenton et al, 2007;Hartung et al, 2005;Joy et al, 2007;Klein and Davis, 1969;Leucht et al, 2009;Leucht et al, 2013a;Matar and Almerie, 2007;Omori and Wang, 2009;Shen et al, 2012).…”

Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments

“……”

“……”